| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
ANTXR1 (TEM8) overexpression in gastric adenocarcinoma makes the protein a potential target of immunotherapy
|
Sotoudeh, Masoud
|
|
2019
|
68 |
10 |
p. 1597-1603
|
article
|
| 2 |
Conventional CARs versus modular CARs
|
Feldmann, Anja
|
|
2019
|
68 |
10 |
p. 1713-1719
|
article
|
| 3 |
Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression
|
Siozopoulou, Vasiliki
|
|
2019
|
68 |
10 |
p. 1573-1583
|
article
|
| 4 |
Gastrin vaccine improves response to immune checkpoint antibody in murine pancreatic cancer by altering the tumor microenvironment
|
Osborne, Nicholas
|
|
2019
|
68 |
10 |
p. 1635-1648
|
article
|
| 5 |
Increased indoleamine 2,3-dioxygenase activity and expression in prostate cancer following targeted immunotherapy
|
Zahm, Chris D.
|
|
2019
|
68 |
10 |
p. 1661-1669
|
article
|
| 6 |
Induction of tumor-specific CD8+ cytotoxic T lymphocytes from naïve human T cells by using Mycobacterium-derived mycolic acid and lipoarabinomannan-stimulated dendritic cells
|
Tomita, Yuji
|
|
2019
|
68 |
10 |
p. 1605-1619
|
article
|
| 7 |
Natural killer cells control metastasis via structural editing of primary tumors in mice
|
Isaacson, Batya
|
|
2019
|
68 |
10 |
p. 1721-1724
|
article
|
| 8 |
Peripheral changes in immune cell populations and soluble mediators after anti-PD-1 therapy in non-small cell lung cancer and renal cell carcinoma patients
|
Juliá, Estefanía Paula
|
|
2019
|
68 |
10 |
p. 1585-1596
|
article
|
| 9 |
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients
|
Milcent, Benoit
|
|
2019
|
68 |
10 |
p. 1561-1572
|
article
|
| 10 |
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor
|
Fujimura, Akiko
|
|
2019
|
68 |
10 |
p. 1649-1660
|
article
|
| 11 |
T cell engineering for adoptive T cell therapy: safety and receptor avidity
|
D’Ippolito, Elvira
|
|
2019
|
68 |
10 |
p. 1701-1712
|
article
|
| 12 |
The BRCA2 mutation status shapes the immune phenotype of prostate cancer
|
Jenzer, Maximilian
|
|
2019
|
68 |
10 |
p. 1621-1633
|
article
|
| 13 |
The role of immune infiltrates as prognostic biomarkers in patients with breast cancer
|
Baxevanis, Constantin N.
|
|
2019
|
68 |
10 |
p. 1671-1680
|
article
|
| 14 |
“Tumor Immunology Meets Oncology (TIMO) XIV”, May 24–26th 2018, Halle/Saale, Germany
|
Steven, André
|
|
2019
|
68 |
10 |
p. 1725-1732
|
article
|
| 15 |
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy
|
Friedrich, Michael
|
|
2019
|
68 |
10 |
p. 1689-1700
|
article
|
| 16 |
Unlocking the therapeutic potential of primary tumor-draining lymph nodes
|
Rotman, Jossie
|
|
2019
|
68 |
10 |
p. 1681-1688
|
article
|
Journal description